FDA
approval
· 2022-09-27
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Apotex Corp.)
Summary
The FDA approved a supplemental application from Apotex Corp. for a generic amlodipine/atorvastatin combination tablet.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)